Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/14737159.2021.1913123 http://scihub22266oqcxt.onion/10.1080/14737159.2021.1913123 33840347!8054491!33840347     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Mol+Diagn 2021 ; 21 (4): 363-370 Nephropedia Template TP {{tp|p=33840347|t=2021. Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies |pdf=|usr=}}{{33840347}} gab.com Text Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies JO: Expert Rev Mol Diagn http://www.kidney.de/pget.php?&tw=1&pmid=33840347 #FOAvip Background: Rapid Lateral Flow Test (LFT) has been broadly utilized in detection or diagnosis of numerous disease-related antigens and antibodies. It is the most popular format of point-of-care test (POCT) and quickest and easiest way to detect a targeted molecule. In the combat against COVID-19 pandemic, hundreds of POCTs have been developed and are commercially available now. They are designed to detect either a SARS-CoV-2 viral antigen or IgG and IgM antibodies binding to it. Among the binding antibodies, a special type of functional antibodies that block the interaction between SARS-CoV-2 virus and its human receptor, neutralizing antibodies (NAbs), are of particular interest to public as well as in vaccination management. However as of today, POCTs for the detection of SARS-CoV-2 NAbs remain under late stage of development.Scope and method:In this review, we first summarize the importance of awareness and monitoring of SARS-CoV-2 NAbs in the combat against COVID-19 pandemic. Secondly, we compare the available methods for the detection of SARS-CoV-2 NAbs. Next, we describe challenges in the development of a rapid lateral flow test for the detection of SARS-CoV-2 NAbs. Finally, we outline its product formats and applications in research and in disease management. Conclusion:Vaccine effectiveness is unknown for an individual unless measured. NAb level is the most viable measurement for vaccine effectiveness or immunity. A broadly accessible NAb POCT is urgently needed. Twit Text FOAVip Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies ????Expert Rev Mol Diagn http://www.kidney.de/pget.php?&tw=1&pmid=33840347 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33840347 #FOAvip English Wikipedia <ref>{{Cite pmid|33840347}}</ref> Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies #MMPMID33840347 Wang JJ; Zhang N; Richardson SA; Wu JV Expert Rev Mol Diagn 2021[Apr]; 21 (4): 363-370 PMID33840347show ga Background: Rapid Lateral Flow Test (LFT) has been broadly utilized in detection or diagnosis of numerous disease-related antigens and antibodies. It is the most popular format of point-of-care test (POCT) and quickest and easiest way to detect a targeted molecule. In the combat against COVID-19 pandemic, hundreds of POCTs have been developed and are commercially available now. They are designed to detect either a SARS-CoV-2 viral antigen or IgG and IgM antibodies binding to it. Among the binding antibodies, a special type of functional antibodies that block the interaction between SARS-CoV-2 virus and its human receptor, neutralizing antibodies (NAbs), are of particular interest to public as well as in vaccination management. However as of today, POCTs for the detection of SARS-CoV-2 NAbs remain under late stage of development.Scope and method:In this review, we first summarize the importance of awareness and monitoring of SARS-CoV-2 NAbs in the combat against COVID-19 pandemic. Secondly, we compare the available methods for the detection of SARS-CoV-2 NAbs. Next, we describe challenges in the development of a rapid lateral flow test for the detection of SARS-CoV-2 NAbs. Finally, we outline its product formats and applications in research and in disease management. Conclusion:Vaccine effectiveness is unknown for an individual unless measured. NAb level is the most viable measurement for vaccine effectiveness or immunity. A broadly accessible NAb POCT is urgently needed. |Antibodies, Neutralizing/analysis/*blood/immunology[MESH] |Antibodies, Viral/blood[MESH] |COVID-19/*immunology/virology[MESH] |Humans[MESH] |Immunoassay/*methods[MESH] |Neutralization Tests/methods[MESH]Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing (epmc).pdf DeepDyve Pubget Overpricing